2026 Peter D.R. Higgins: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	87	13595	12793	6908	6389	518	29185

Overview

Peter D.R. Higgins is affiliated with the University of Michigan-Ann Arbor in the United States. Their research primarily focuses on medicine and biochemistry, genetics, and molecular biology, with substantial contributions in genetics, epidemiology, surgery, infectious diseases, and ecology, evolution, behavior, and systematics.

Their scholarly work centers on topics such as inflammatory bowel disease, microscopic colitis, plant and animal studies, insect and arachnid ecology and behavior, eosinophilic esophagitis, autoimmune and inflammatory disorders, and insect and pesticide research.

Peter D.R. Higgins has published extensively, with notable frequent publication venues including:

Birds of the World
Gastroenterology
Inflammatory Bowel Diseases
The American Journal of Gastroenterology
bioRxiv (Cold Spring Harbor Laboratory)

Their recent papers include:

Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials (2022, The Lancet)
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk (2020, Circulation)
Management of Crohn Disease (2021, JAMA)
Increased Intestinal Permeability Is Associated With Later Development of Crohn's Disease (2020, Gastroenterology)
Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis (2020, Gastroenterology)

Frequent collaborators in their research include:

Les Christidis
Hugh Ford
Jeffrey Berinstein
Shirley Cohen-Mekelburg
Shrinivas Bishu

Best Publications

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

Wolfgang Hueber;Bruce E Sands;Steve Lewitzky;Marc Vandemeulebroecke

1619
Citations
Epidemiology of Constipation in North America: A systematic review

Peter D.R. Higgins;John F. Johanson

1462
Citations
Statins and the Risk of Colorectal Cancer

Jenny N. Poynter;Stephen B. Gruber;Peter D.R. Higgins;Ronit Almog

1000
Citations
Statins and cancer prevention

Marie-France Demierre;Peter D. R. Higgins;Stephen B. Gruber;Ernest Hawk

964
Citations
Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.

A. Singal;M. L. Volk;A. Waljee;R. Salgia

931
Citations
A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis

B. Joseph Elmunzer;James M. Scheiman;Glen A. Lehman;Amitabh Chak

846
Citations
A primer on effectiveness and efficacy trials.

Amit G Singal;Peter D R Higgins;Akbar K Waljee

708
Citations
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose, and How to Predict Response

Geert R. D'Haens;Remo Panaccione;Peter D.R. Higgins;Severine Vermeire

577
Citations
Comparison of imputation methods for missing laboratory data in medicine

Akbar K. Waljee;Ashin Mukherjee;Amit G. Singal;Yiwei Zhang

425
Citations
European evidence-based consensus: Inflammatory bowel disease and malignancies

Vito Annese;Laurent Beaugerie;Laurence Egan;Livia Biancone

420
Citations
The human gut microbiome: current knowledge, challenges, and future directions

Maneesh Dave;Peter D. Higgins;Sumit Middha;Kevin P. Rioux

410
Citations
Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis

Akbar Waljee;Jennifer Waljee;Arden Morris;Peter D.R. Higgins

403
Citations
A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis

Badih Joseph Elmunzer;Akbar K Waljee;Grace H Elta;Jason R Taylor

392
Citations
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials

Julian Panés;William J. Sandborn;Stefan Schreiber;Bruce E. Sands

356
Citations
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection

Miguel Regueiro;Brian G. Feagan;Bin Zou;Jewel Johanns

322
Citations
Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability.

Jay Luther;Peter D R Higgins;Phillip S Schoenfeld;Paul Moayyedi

307
Citations
Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn’s Disease: A Phase 2a Study

Bruce E. Sands;Jingjing Chen;Brian G. Feagan;Mark Penney

303
Citations
Association between Helicobacter pylori infection and inflammatory bowel disease: A meta-analysis and systematic review of the literature†

Jay Luther;Maneesh Dave;Peter D.R. Higgins;John Y. Kao

299
Citations
Systematic review: the epidemiology of ischaemic colitis.

P. D. R. Higgins;K. J. Davis;L. Laine

290
Citations
Primary Sclerosing Cholangitis: Meta-Analysis of Diagnostic Performance of MR Cholangiopancreatography

Maneesh Dave;B. Joseph Elmunzer;Ben A. Dwamena;Peter D.R. Higgins

288
Citations

Frequent Co-Authors

Bruce E. Sands Icahn School of Medicine at Mount Sinai

Brian G. Feagan University of Western Ontario

Vincent B. Young University of Michigan–Ann Arbor

Severine Vermeire KU Leuven

William J. Sandborn University of California, San Diego

Silvio Danese Vita-Salute San Raffaele University

Remo Panaccione University of Calgary

Jason R. Spence University of Michigan–Ann Arbor

Julián Panés University of Barcelona

Geert R. D'Haens University of Amsterdam

External Links

Personal website of Peter D.R. Higgins

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Exploring alternative online degrees and career pathways can open up new opportunities in the field of healthcare. For registered nurses interested in career advancement, adn to np programs offer a flexible path to become nurse practitioners without starting from scratch. Similarly, those who want to enhance their nursing credentials can consider online rn-bsn programs without clinicals, which allow nurses to earn their bachelor’s degree while continuing to work.

Beyond nursing, there are reputable degrees for aspiring healthcare managers. The cahme accredited online mha programs list features programs that meet rigorous industry standards, preparing graduates for leadership roles in healthcare administration.

For those passionate about preventive care and wellness, an online degree in nutrition provides foundational knowledge for careers in dietetics or health education. Each of these pathways can help broaden your impact in healthcare—even if you choose not to pursue a traditional Doctor of Medicine degree in the USA.